Molecular Diagnostics
Africa · 3 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Africa Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Type, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$712.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $326.8 Mn | — | — |
| 2025 (base) | $368.3 Mn | +$41.5 Mn | — |
| 2026 (forecast) | $415.1 Mn | +$46.8 Mn | +12.7% |
| 2027 (forecast) | $467.8 Mn | +$52.7 Mn | +27% |
| 2028 (forecast) | $527.3 Mn | +$59.4 Mn | +43.1% |
| 2029 (forecast) | $594.2 Mn | +$67.0 Mn | +61.3% |
| 2030 (forecast) | $669.7 Mn | +$75.5 Mn | +81.8% |
| 2031 (forecast) | $754.7 Mn | +$85.0 Mn | +104.9% |
| 2032 (forecast) | $850.6 Mn | +$95.9 Mn | +130.9% |
| 2033 (forecast) | $958.6 Mn | +$108.0 Mn | +160.3% |
| 2034 (forecast) | $1.08 Bn | +$121.7 Mn | +193.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $368.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.08 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, technology and end user (see all) |
| Key players | Myriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and 1 more (see all) |
| Regulator in Africa | AMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Genetic testing reads a person's DNA to find inherited conditions, cancer risk, drug response and family links.
Key segments of the genetic testing market include type (Predictive Testing, Carrier Testing and Diagnostic Testing) and technology (PCR, Sequencing and Microarrays).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the genetic testing market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the genetic testing market.
The genetic testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3], SAHPRA (South Africa)[4] and NAFDAC (Nigeria)[5]. How care is paid for in some of these countries: universal health insurance (Egypt)[6], the SHA (Kenya)[7], planned National Health Insurance (South Africa)[8] and out of pocket and the NHIA (Nigeria)[9].
[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
[2] Egyptian Drug Authority. Checked 14 Nov 2026.
[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.
[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[5] NAFDAC. Checked 19 Nov 2026.
[6] Universal Health Insurance Authority. Checked 14 Nov 2026.
[7] Social Health Authority. Checked 14 Nov 2026.
[8] National Department of Health. Checked 14 Nov 2026.
[9] National Health Insurance Authority (NHIA). Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how genetic testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
From our blog
Africa · 3 shared keywords
Africa · 2 shared keywords
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa
Pharmaceuticals · Africa
Digital Health · Africa
Healthcare Services · Africa
Healthcare Services · Africa
Digital Health · Africa
Healthcare Services · Africa